Skin wounds associated with calciphylaxis in end-stage renal disease patients on dialysis

Nutrition

Volumn 26, Issue 9, 2010, Pages 910-914

  Sulková, Sylvie Dusilová ^a   Válek, Martin ^b,c  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Calcific uremic arteriopathy; Calcio phosphate metabolism; Calciphylaxis; Chronic renal failure; Dialysis

Indexed keywords

C REACTIVE PROTEIN; CALCIUM; CINACALCET; CLINDAMYCIN; INSULIN; LANTHANUM CARBONATE; PAMIDRONIC ACID; PARATHYROID HORMONE; PARICALCITOL; PHOSPHATE BINDING AGENT; PHOSPHORUS; WARFARIN;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CALCINOSIS; CALCIUM BLOOD LEVEL; CASE REPORT; CHRONIC KIDNEY FAILURE; DISEASE ASSOCIATION; FEMALE; HEMODIALYSIS; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUS; RASH; SECONDARY HYPERPARATHYROIDISM; SKIN BIOPSY; SKIN DEFECT; SKIN DISCOLORATION; SKIN INDURATION; SKIN NECROSIS; THIGH; WOUND; WOUND CARE; WOUND HEALING; WOUND INFECTION;

EID: 77955362042     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2010.01.018     Document Type: Article

References (18)

1. Kuypers D.R. Skin problems in chronic kidney disease. Nat Clin Pract Nephrol 2009, 5:157-170.
2. Rogers N.M., Coates P.T.H. Calcific uraemic arteriolopathy: an update. Curr Opinion Nephrol Hypertens 2008, 17:629-634.
3. Rogers N.M., Teubner D.J.O., Coates P.T.H. Calcific uremic arteriolopathy: advances in pathogenesis and treatment. Semin Dial 2007, 20:150-157.
4. Burke S.K. Phosphate is a uremic toxin. J Ren Nutr 2008, 18:27-32.
5. Cozzolino M., Gallieni M., Brancaccio D. The mechanisms of hyperphosphatemia-induced vascular calcification. Int J Artif Organs 2008, 31:1002-1003.
6. Nikolov I.G., Mozar A., Drüeke T.B., Massy Z.A. Impact of disturbances of calcium and phosphate metabolism on vascular calcification and clinical outcomes in patients with chronic kidney disease. Blood Purif 2009, 27:350-359.
7. Weenig R.H., Sewell L.D., Davis M.D., McCarthy J.T., Pittelkow M.R. Calciphylaxis: natural history, risk factor analysis, and outcome. Am J Acad Dermatol 2007, 56:569-579.
8. Mazhar A.R., Johnson R.J., Fillem D., Stivelman J.C., Ryan M.J., Davis C.L., Stehman-Breen C.O. Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kid Int 2001, 60:324-332.
9. Nigwekar S.U., Wolf M., Sterns R.H., Hix J.K. Calciphylaxis from nonuremic causes: a systematic review. Clin J Am Soc Nephrol 2008, 3:1139-1143.
10. Arseculeratne G., Evans A.T., Morley S.M. Calciphylaxis--a topical overview. J Eur Acad Der Venerol 2006, 20:493-502.
11. Hayden M.R., Goldsmith D., Sowers J.R., Khanna R. Calciphylaxis: calcific uremic arteriolopathy and the emerging role of sodium thiosulfate. Int Urol Nephrol 2008, 40:443-451.
12. Raymond C.B., Wazny L.D. Sodium thiosulfate, bisfospfonates, and cinacalcet for treatment of calciphylaxis. Am J Health Syst Pharm 2008, 65:1419-1429.
13. Monney P., Nguzen Q.V., Perroud H., Descobes E. Rapid improvement of calciphylaxis after intravenous pamidronate therapy in patients with chronic renal failure. Nephrol Dial Transplant 2004, 19:2130-2132.
14. Arenales M.D., Gil M.T., Gutierrez M.D., Malek T., Moledous A., Salinas A., Alvarez-Ude F. Management of calcific uremic arteriolopathy (calciphylaxis) with a combination of treatments, including hyperbaric oxygen therapy. Clin Nephrol 2008, 70:261-264.
15. Basile C., Montanaro A., Masi M., Pati G., De Maio P., Gismondi A. Hyperbaric oxygen therapy for calcific uremic arteriolopathy: a case series. J Nephrol 2002, 15:676-680.
16. K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis 2003, 42(suppl 3):S1-S202. National Kidney Foundation.
17. Hafner J., Keusch G., Wahl C., Sauter B., Hürlimann A., von Weizsäcker F., et al. Uremic small-artery disease with medial calcification and intimal hyperplasia (so-called calciphylaxis): a complication of chronic renal failure and benefit from parathyreoidectomy. J Am Acad Dermatol 1995, 33:954-962.
18. Girotto J.A., Harmon J.W., Retner L.E., Nicol T.L., Wong L., Chen H. Parathyreoidectomy promotes wound healing and prolongs survival in patiens with calciphylaxis from secondary hyperparathyroidism. Surgery 2001, 130:645-651.